America’s Blood Centers (ABC) submitted joint comments to the docket on June 5, 2020 with AABB, American Red Cross (ARC), and the Plasma Protein Therapeutics Association (PPTA) on “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products”, April 2020. Again, we appreciate the FDA’s efforts to support the blood industry during the COVID-19 public health emergency by revising the guidance to allow additional blood donors during the inventory shortage.
ABC wants to supplement these comments and bring to your attention the need for an immediate technical correction to this guidance.
Posted in Letters and Comments